Sitemap
Sections
Tags
- 1D00C3
- 23andMe
- 454 Life Sciences
- 6R-BH4
- A.P. Pharma
- AAB-001
- Aastrom Biosciences
- Abbott Labs
- Abgenix
- Abingdon Life Sciences
- Abiomed
- Ablynx
- Abraxane
- Abraxis Pharmaceutical
- ABSORB
- Acadia Pharmaceuticals
- ACAM2000
- Acambis
- Acanya
- ACC-001
- Accelerator Corporation
- Acceleron
- Accentia Pharmaceuticals
- Accera
- Accupril
- ACE-031
- AcelleRX Therapeutics
- Aclasta
- acomplia
- Acorda Therapeutics
- ACP-104
- ACP-106
- actavis
- Actelion
- Actemra
- Actimis
- Actos
- ACU-4492
- Acucela
- Acura Pharmaceuticals
- Acusphere
- ACX10061
- ACZ885
- AD 337
- Adams Respiratory
- AdcockIngram
- Adderall
- Addex Pharmaceuticals
- Adenosine Therapeutics
- Adeona Pharmaceuticals
- ADH-1
- ADHD
- ADHD patch
- Adherex
- Adimab
- adjuvant
- Adlea
- Adnexus Therapeutics
- Adolor
- Advagraf
- Advair
- Advanced Cell Technology
- Advanced Life Sciences
- Advancis Pharmaceutical
- AdvanDx
- Advaxis
- ADVENTRX Pharmaceuticals
- adverse events
- Advexin
- Advinus
- ADX10059
- Aegerion Pharmaceuticals
- AEGR-733
- Aeolus Pharmaceuticals
- AeroLEF
- AEterna Zentaris
- AEZS-108
- Affymax
- affymetrix
- Aflibercept
- afluria
- Afresa
- Africa
- age related macular degeneration
- Agendia
- Agensys
- AGI-1067
- Agile Therapeutics
- Aging
- Agios Pharmaceuticals
- Agros Therapeutics
- Aidan King
- Aileron Therapeutics
- AkaRx
- Akorn
- AKR-501
- Akten
- Akzo Nobel
- Alan Frazier
- Alan Levin
- Alan Trounson
- Alba Bioscience
- Albany Molecular Research
- Albuferon
- Alcon
- Aldagen
- Alder Biopharmaceuticals
- Alessandro Banchi
- Alex Gorsky
- Alexander Fleming
- Alexion Pharmaceuticals
- Alexza Pharmaceuticals
- Alfacell
- Algeta
- Alimera Sciences
- Alimta
- Alkermes
- Allergan
- Allergy Therapeutics
- alli
- Allos
- Allyson Schwartz
- almorexant
- Alnara Pharmaceuticals
- Alnylam
- Alnylam Pharmaceuticals
- alogliptin
- AlphaGenix
- Alpharma
- AlphaVax
- ALS-357
- Alseres Pharmaceuticals
- Altabax
- altana
- Altor BioScience
- Altus Pharmaceuticals
- alvimopan
- Alvine Pharmaceuticals
- Alzheimer's
- Alzhemed
- AM240 MCR
- AMAG Pharmaceuticals
- Amarin
- AmbioPharm
- Ambit Biosciences
- Ambrilia Biopharma
- Ambrx
- American Cancer Society
- American Medical Association
- AmerisourceBergen
- Amgen
- Amicus Therapeutics
- Amir Nashat
- Amoxicillin
- Amplimed
- AMR Technology
- Amulet Pharmaceuticals
- Amylin pharmaceuticals
- amyotrophic lateral sclerosis
- Amyris Biotechnologies
- ANA975
- anacetrapib
- Anacor Pharmaceuticals
- Anadys Pharmaceuticals
- analysts
- AnaMar Medical
- Anaphore
- Anaptys Biosciences
- Anders Ekblom
- Andreas Struengmann
- Andrew von Eschenbach
- Andrew Witty
- Andrin Oswald
- Andrx
- Anemia drugs
- Anesiva
- Angiocept
- Angiomax
- Angiotech Pharmaceuticals
- Angiotensin
- anidulafungin
- Anika Therapeutics
- Animal Libertaion Front
- Ann Arbor
- Anne Wojcicki
- Anormed
- Antares Pharma
- Anthera
- anthrax
- anthrax vaccine
- anti-counterfeiting
- Anti-TNF
- antibiotic
- antibodies
- Antibody 806
- antidepressant
- antigen
- Antigenics
- antisense
- Antisense Pharma
- Antisoma
- antithrombotic theory
- antiviral drug
- ANX-514
- ANX-530
- AP23573
- apaziquone
- APD125
- Apitope Technology
- apixaban
- Aplenzin
- Apogenix
- Apotex
- Applied Biosystems
- Approvable letter
- APT Pharmaceuticals
- Aptuit
- Aradigm
- Arana Therapeutics
- Aranesp
- ARCA
- Arcalyst
- Archemix
- Archer Pharmaceuticals
- Archimedes
- Arcion Therapeutics
- Arcutis
- Ardana
- Ardea BioSciences
- Arena Pharmaceuticals
- Arete Therapeutics
- arGentis
- Arginetix
- Argos Therapeutics
- ARIAD Gene Therapeutics
- Ariad Pharmaceuticals
- Arius
- Arizona
- Ark Therapeutics
- Arlene Chiu
- Arnold Schwarzenegger
- Arpida
- ARQ 197
- ArQule
- Array BioPharma
- Arriva
- Arrow International Limited
- ART104
- arthritis
- Arthur Higgins
- Arthur Levinson
- Aryx Therapeutics
- AS1404
- ASA404
- Ascendis Pharma
- Ascent Therapeutics
- ASCO
- Asenapine
- Asentar
- Asia
- Aspen Technology
- Asphelia Pharmaceuticals
- Aspreva Pharmaceuticals
- assets
- Astelin
- Astellas Pharma
- Astepro
- Asterand
- Astex Therapeutics
- asthma
- AstraZeneca
- Asuragen
- Athenagen
- Atherogenics
- Atherosclerosis
- Athersys
- atiplatelets
- Atlantos
- Atlas Venture
- Atria
- atrial fibrillation
- Atrium Innovations
- ATryn
- Auriga Laboratories
- Aurigene
- Auspex Pharmaceuticals
- Australia
- autoimmune disease
- Auxilium Pharmaceuticals
- Avalon Pharmaceuticals
- Avandia
- Avanir Pharmaceuticals
- Avant Immunotherapeutics
- Avantome
- Avastin
- Avelox
- AVEO Pharmaceuticals
- Averion
- Avexa
- Avian Flu
- Avian flu pandemic
- Avian flu vaccine
- avian flu virus
- Avigen
- AVN316
- AVN994
- Axcan Pharma
- Axona
- AZ-002
- AZ-004
- AZD1446
- AZD3480
- Azilect
- Azur Pharma
- BA058
- baldness therapies
- Balsalazide
- Baltimore
- Baminercept
- bankruptcy
- bapineuzumab
- Barack Obama
- Baraclude
- Barr Pharmaceuticals
- Barrier Therapeutics
- Basilea
- Bausch & Lomb
- Bavarian Nordic
- Baxter
- Baxter International
- Bayer Healthcare
- Bayer Schering
- Bazedoxifene
- BCI-540
- BDSI
- Belgium
- belinostat
- Bellco Health
- benign prostatic hyperplasia
- Bentley Pharmaceuticals
- Berkely HeartLab
- Berna Biotech
- Bernard Poussot
- Betagenon
- Betaseron
- Bextra
- BG Medicine
- BG-12
- BGC 945
- bicifadine
- Bidil
- Big Biotech
- Big Pharma
- Bill and Melinda Gates Foundation
- Bill Wells
- Billionaire
- BIND Biosciences
- Binocrit
- BIO
- BIO 2008
- Bioalliance Pharma
- Biocompatibles International
- Biocon
- Biocryst
- biodefense
- Biodel
- BioDelivery Sciences
- BioDuro
- Bioenvision
- BioFocus DPI
- Biogen Idec
- Biogenerics
- BioInvent
- Biolex Therapeutics
- Biologics
- BioMarin Pharmaceutical
- biomarkers
- BioMimetic Therapeutics
- Biomira
- BioMS Medical
- Bioniche Life Sciences
- Bionomics
- biopharmaceutical company
- BioProcessors
- biopure
- BioSante
- biosimilar
- BioSpecifics Technologies
- BioSynthema
- Biota
- biotech
- Biotech company news
- biotech drugs
- biotech growth
- biotech investing
- Biotech investor
- Biotech IPO
- Biotech IPO
- biotech jobs
- biotech news
- biotech patent news
- biotech revolution
- Biotech Stock
- biotech stocks
- Biotech Venture Capital
- biotechnology
- biotechnology company
- Biotest
- Biothera
- BioThorpe
- BioTie
- BioTie Therapies
- Biovail
- BiovaxID
- Biovest International
- BioVex
- Biovitrum
- Bipolar
- birth control
- BLA
- Black Box Warning
- Bladder Cancer
- blinatumomab
- blockbusters
- blood cancer
- blood clots
- blood pressure
- blood substitute
- boceprevir
- Boda
- Boehringer Ingelheim
- bone cancer
- Boostrix
- Boston
- Boston Scientific
- Botox
- Bradley Pharma
- brain cancer
- brain disease
- BrainCells
- breast cancer
- Bremelanotide
- Brent Norton
- Bridion
- Briggs Morrison
- Bristol-Myers Squibb
- Broad Institute
- Brostallicin
- Bruce Boise
- Bryan Lawis
- Bryan Morton
- BTG
- bucindolol
- Budesonide
- Buprenorphine
- Bush Administration
- business development
- Busulfex
- buyout
- buyouts
- Byetta
- C.R. Bard
- California
- California Institute for Regenerative Medicine
- Calistoga Pharmaceuticals
- Callisto Medical
- Cambria Biosciences
- Cambria Pharmaceuticals
- Cambridge
- cambridge antibody technology
- Cambridge Company
- cambridge massachusetts
- Campath
- Canaccord Capital
- Canada
- Cancer
- cancer drug
- Cancer Drugs
- cancer pain
- cancer research
- Cancer Therapeutics CRC
- cancer therapies
- cancer vaccine
- Cancidas
- Cangene
- Cannabinoids
- Canopus BioPharma
- capital partners
- Cara Therapeutics
- Caraco Pharmaceutical Laboratories
- Cardene
- Cardiology
- Cardiome Pharma
- Cardiovascular Biotherapeutics
- cardiovascular risks
- Cariprazine
- Carisbamate
- Carl Icahn
- Carlo Paribello
- Carlos Paya
- Carol Gallagher
- Carrolee Barlow
- case studies
- Castle Biosciences
- Catalyst Biosciences
- Catalyst Pharmaceutical
- CD103
- CDC
- CDX-110
- ceftobiprole
- Cel-Sci
- Celacade
- Celator Pharmaceuticals
- Celebrex
- Celera
- Celgene
- Cell Genesys
- Cell Therapeutics
- CellCentric
- CellCept
- CellCyte
- Celldex Therapeutics
- Cellerix
- cells
- Cellular Dynamics
- Cellzome
- Celsion
- Celtic Pharma
- Celtic Pharmaceutical
- CeNeRx BioPharma
- Cenomed BioSciences
- Centocor
- central nervous system
- CEO
- CEO pay
- Cephalon
- Ceplene
- Ception Therapeutics
- Cequent Pharmaceuticals
- Ceragenix
- Ceragenix Pharmaceuticals
- Cerepro
- Ceres
- Cervarix
- cervical cancer
- cervical cancer vaccine
- cethromycin
- CETP inhibitors
- Cetrorelix
- CFO
- Chad Therapeutics
- Chandrix
- Charles Baum
- Charles Butt
- Charles Grassley
- Charles River
- Chelsea Therapeutics
- ChemBridge
- ChemDiv
- ChemGenex
- Chemokine Therapeutics
- chemotherapy
- chief medical officer
- chief operating officer
- chief scientific officer
- China
- China Aoxing
- China Pharma Holdings
- China SFDA
- China SFDA approval
- China Sky One Medical
- China West
- Chinese Academy of Merical Sciences
- Chiron
- Chmp
- cholesterol
- cholesterol drug
- Chris Brinsmead
- Chris Newton
- Chris Viehbacher
- Christy Shaffer
- Chromatin
- Chronic Idiopathic Constipation
- chronic lymphocytic leukemia
- Chugai
- Chutes and Ladders
- Cialis
- CIDP
- cilomilast
- Cimzia
- Cinryze
- Circassia
- CK-1827452
- Claratin
- Claritin
- Clarus Ventures
- Class Action
- clean tech
- Cleveland Clinic
- Cleviprex
- Clinical Data
- Clinical Development
- Clinical Trial
- Clinical trial news
- Clinical Trial Results
- Clinical Trials
- ClinPhone
- cloning
- clostridium difficile
- Clyclacel
- CNTO 1275
- Coartem
- Codexis
- Cofactor
- Cogentus Pharmaceuticals
- Col-118
- Colazal
- Collaboration Agreement
- collaborations
- CollaGenex Pharmaceuticals
- CollaRx
- colon cancer
- Colorado
- colorectal cancer
- CoLucid
- CoLucid Pharmaceuticals
- Columbia Laboratories
- Columbia University Medical Center
- combination
- combinatorx
- combined company
- combo drug
- CoMentis
- commercialization
- Commercialization deals
- Commonwealth Biotechnologies
- competitors
- Compugen
- Computer Model
- Concert Pharmaceutcals
- Concert Pharmaceuticals
- Congress
- Connecticut
- Constellation Pharma
- Constellation Pharmaceuticals
- contraceptive
- Contrave
- controversy
- Copaxone
- COPD
- CORDAPTIVE
- Coreg
- Corey Goodman
- Corgentech
- Coria Laboratories
- corifollitropin alfa
- Cork
- Cornerstone BioPharma
- Cortex Pharmaceutcials
- Corthera
- Cougar Biotechnology
- counterfeit drugs
- Covance
- Covidien
- Cowen Healthcare Royalty Partners
- cox 2 inhibitor
- cox 2 inhibitors
- CP-945598
- CPEX Pharmaceuticals
- CPX-351
- CR014
- Craig Tooman
- Crestor
- Critial Path Initiative
- Critical Pharmaceuticals
- critical therapeutics
- critics
- CRO
- Crohn's disease
- Crucell
- Cryo-Cell
- CRYSTAL study
- CrystalGenomics
- CSL
- CTEP inhibitors
- CU-2010
- Cubicin
- Cubist Pharmaceuticals
- Curacyte
- curagen
- Curis
- Curt Selquist
- CV Therapeutics
- CX717
- cybrids
- Cyclacel
- Cyclofluidic
- Cydex Pharmaceuticals
- Cylene Pharmaceuticals
- Cymbalta
- Cyntellect
- Cypress
- Cypress Bioscience
- cystic fibrosis
- CytImmune Sciences
- Cytochroma
- CytoFab
- Cytogen
- CytoGenix
- cytokinetics
- Cytopia
- Cytos
- Cytos Biotechnology
- CytRx
- Czech Republic
- d center
- Dacogen
- Daiichi Sankyo
- dalbavancin
- Daniel Adams
- Daniel S. Goldberg
- Daniel Vasella
- Daniel Zurr
- dapagliflozin
- DARA BioSciences
- darmstadt germany
- data monitoring committee
- Dave Holveck
- David Baltimore
- David Brennan
- David Eveleth
- David Ginsberg
- David Heimbrook
- David Holveck
- David Hung
- David J. Mazzo
- David Mackney
- David Mazzo
- David Mott
- David Murdock
- David Pritchard
- deal
- Deals
- Deals
- Debiopharm
- Deciphera Pharmaceuticals
- Decode Genetics
- deforolimus
- Degarelix
- Delcath
- Democrats
- Dendreon
- Denmark
- Denosumab
- Denver
- Department of Defense
- Department of Health and Human Services
- DepoDur
- Depomed
- depression
- DermaTech
- Desmoteplase
- Deval Patrick
- development costs
- Development deals
- Devgen
- DIA
- Diabetes
- Diakron Pharmaceuticals
- Diangostics
- Diasome Pharmaceuticals
- Dicerna Pharmaceuticals
- Difluprednate
- Dimebon
- Dimera
- Diractin
- Direvo
- Direvo Biotech
- dirucotide
- Discovery Labs
- doctors
- dopamine
- Dopexamine
- Dor BioPharma
- Doribax
- Douglas Squires
- Dov Pharmaceutical
- Dow Pharmaceutical Sciences
- Doxil
- DPP-4 inhibitors
- DPP-4 inhibitors. diabetes
- Dr. Reddy
- Dr. Reddy's
- Dr. Steven Nissen
- Draper Laborator
- Drew Faust
- Droxidopa
- Drug approvals
- drug candidates
- drug combination
- drug delivery technologies
- drug delivery technology
- drug developer
- Drug Development
- Drug Discovery
- drug marketing
- drug prices
- Drug repositioning
- drug reprofiling
- Drug Resistance
- Drug Safety
- Drug Trials
- Drug-Induced Human Liver Injury
- DSM Biologics
- DTC advertising
- Duke University
- Duramed Pharmaceuticals
- Dusa Pharmaceuticals
- Duska Therapeutics
- DX-88
- Dyadic
- Dyax
- Dynavax
- Dynavax Technologies
- dysmenorrhea
- dysmenorrheal
- earnings
- Ebola Hemorrhagic Fever
- ECLIPSE study
- Economic development
- eculizumab
- EDEN Bioscience
- efalizumab
- efavirenx
- Effient
- Egg-based
- Eisai
- EKR Therapeutics
- Elafin
- Elan
- Elan Drug Technologies
- Elbion
- Election 2008
- elesclomol
- Eli and Edythe Broad
- Eli Lilly
- Elias Zerhouni
- Elixir Pharmaceuticals
- Ellen McDonald
- elotuzumab
- Elusys Therapeutics
- Embeda
- embryonic stem cell
- embryonic stem cells
- EMD Serono
- EMEA
- EMEA Approval
- Emergent BioSolutions
- Emerging Drug Developer
- Emerging Drug Developer; Synta Pharmaceuticals
- emerging markets
- emerging outsourcing trends
- EmergingMed
- Emisphere
- En Li
- Enbrel
- Encore Therapeutics
- Encorium Group
- Encysive
- Endeavor
- Endo Parmaceuticals
- Endocrinaology
- Enlight Biosciences
- Enobia
- Enobia Pharma
- Ensemble Discovery
- Entelos
- Entereg
- EntreMed
- Entrepreneur
- Entrepreneur. venture capital
- EnVivo
- Enzon Pharmaceuticals
- Enzymatic Therapy
- EpiCept
- EpiCeram
- Epix
- EPIX Pharmaceuticals
- equity investment
- Erbitux
- erectile dysfunction
- Eric Lander
- Erythema
- Erythropoietin
- ES Cell International
- Esai
- ESBATech
- Esperion
- Esperion Therapeutics
- Esprit
- Esprit Pharma
- Essentialis
- Eszopiclone
- etanercept
- Eugene Melnyk
- Europe
- European Commission
- EUSA Pharma
- EvaMist
- Evan Levine
- Evista
- Evotec
- EVT 201
- EXACT Sciences
- Excalibur
- Executives
- Exelixis
- Exeter Life Sciences
- Exparel
- Experimental Drugs
- experimental therapy
- expert advice
- Extends Survival
- Exubera
- Eyegate
- Eyetech
- f-star
- F2695
- Fablyn
- Fabrazyme
- Facet Biotech
- factive
- Faheem Hasnain
- Failed drug program
- fake pharmaceuticals
- Famvir
- FASgen
- Fast Track
- Fast Track designation
- Fast Track designationm
- Fate Therapeutics
- Fauci
- Favrille
- FDA
- FDA approval
- FDA approval & regulation
- FDA delay
- FDA regulation
- FDA rejection
- FDA update
- FDA update
- FDA warning
- federal funding
- federal judge
- female sexual dysfunction
- Femara
- Fentora
- FermaVir
- Ferring Pharmaceuticals
- fertility
- ferumoxytol
- Fibromyalgia
- Fidia Farmaceutici
- FIELD study
- Fierce 15
- financial reports
- finasteride
- FirstPoint Biotech
- Flamel
- Flemming Lindeløv
- Florida
- flu
- flu vaccine
- flu vaccines
- FluBlok
- Fluidigm
- Flumist
- Flurizan
- Flutiform
- FMD Report
- Follica
- foot-and-mouth
- Foradil
- Forbes Medi-Tech
- Forest Lboratories
- Forma Therapeutics
- Formac Pharmaceuticals
- ForteBio
- fospropofol disodium
- Fountain Healthcare Partners
- Fovea
- Fovea Pharmaceuticals
- Fragile X Research
- France
- France Biotech
- Frank Baldino
- Franz Humer
- Fred Eshelman
- Fred Hassan
- Frova
- ftc
- funding
- funding gap
- FV-100
- GA101
- Gabapentin GR
- Gabriel Sciences
- Galantamine Hydrobromide
- Galapagos
- Galderma
- Galenea
- Galenica
- galvus
- Gammagard
- Gamunex
- Ganymed Pharmaceuticals
- Gardasil
- Garo Armen
- Garry Nicholson
- Gary Shearman
- Gattex
- GE
- Gedeon Richter
- gemcitabine
- Gemin X Pharmaceuticals
- Gen-Probe
- Genaera
- Genasense
- Gene Logic
- gene targeting
- gene therapy
- Genelabs Technologies
- GeneNews
- Genentech
- general counsel
- General Electric
- Generex
- Generic
- Generic Biologics
- Generics
- genes
- Genesis Pharmaceuticals
- GeneThera
- genetic model
- genetic test
- Genetically Engineered Animals
- genetics
- GENFIT
- Genitope
- Genizon
- GenMab
- Genocea Biosciences
- Genome
- Genomic Vision
- Genomics
- Genta
- Gentium
- Genvec
- Genzyme
- George Church
- GeoVax
- Gerard Le Fur
- Gerard Martino
- Geron
- gifts
- Gilead
- Gilead Sciences
- glaucoma
- GlaxoSmithKline
- Gleevec
- Glenmark Pharmaceuticals
- Glenn Gormley
- Glide Pharma
- globalization
- GlobeImmune
- GlycArt
- Glyn Edwards
- Goldmans Sachs
- Golimumab
- goliumumab
- Golmumab
- Gordon Brown
- Gordon Wier
- GPC
- GPC Biotech
- Grassley
- GRC 6211
- green initiatives
- Gregory Lucier
- Grupo Ferrer
- GS9411
- GTC Biotherapeutics
- GTC Therapeutics
- GTx
- GVAX
- GVAX immunotherapy
- GW Pharma
- GWAS
- Gwen Krivi
- H. Lundbeck
- H. Stewart Parker
- HAART
- HAE
- Halozyme
- Hana Biosciences
- Handok Pharmaceuticals
- Hank McKinnell
- Haptogen
- Harold Varmus
- Harvard
- Harvard Medical School
- Hawaii Biotech
- HBM Bioventures
- HCD122
- HE3235
- head and neck cancer
- Head Lice
- Healive
- Health Canada
- HealthLinx
- heart disease
- heart drug
- Helix Biopharma
- Helsinn
- Hematide
- Hemispherx Biopharma
- Hemo-Stream
- hemophilia
- Hemopure
- Henri Termeer
- Henry E. Blair
- hepatitis B
- Hepatitis C
- Heplisav
- Herceptin
- hereditary angieoedema
- Heritage Pharmaceuticals
- Hesperion
- High Throughput Genomics
- Hillary Clinton
- HIPAA
- Hirofumi Onosaka
- Histogenics
- HIV/AIDS
- HIV/AIDS
- HIV/AIDS
- HIV/HBV
- Hollis Eden
- Hollis-Eden
- Horizon Therapeutics
- Hospira
- hostile takeover
- Howard Richman
- Hubert Birner
- Human African Tryanosomiasis
- Human Genome Sciences
- human growth hormone
- Humana
- HuMax CD-20
- HuMax-EGFr
- Humira
- Huntington's
- HUYA Bioscience
- HVC-796
- hybrid
- Hycamtin
- Hydra Biosciences
- Hyperion Therapeutics
- hypertension
- HZT-501
- Ian Garland
- iBioPharma
- Ibis Biosciences
- Ibis T5000
- IBM
- Ibraheem Mahmood
- iCardiac Technologies
- icatibant
- iclaprim
- ICON
- Iconix Biosciences
- IDEA
- Idenix Pharmaceuticals
- Idera
- IDM Pharma
- Ikonisys
- Illumina
- iloperidone
- Ilypsa
- ImaRx
- ImaRX Therapeutics
- IMC-1121B
- IMC-11F8
- IMC-A12
- ImClone
- Imitrex
- Immtech
- Immtech Pharmaceuticals
- Immune Design
- immune response
- immune system
- Immunocore
- ImmunoGen
- Immunosyn
- immununotherapy
- ImmuPharma
- IMO-2055
- IMPAX
- IMS Health
- Imvamune
- IND
- Indai
- Indevus
- Indevus Pharmaceuticals
- India
- indication
- IndiPharm
- Indonesia
- Inex Pharmaceuticals
- InfaCare Pharmaceutical
- infectious disease
- infectious diseases
- Infinity Pharmaceuticals
- inflammatory conditions
- inflammatory diseases
- injectable
- InNexus Biotechnology
- Innocoll
- Innogenetics
- Innopharm
- Innovative Medicines Initiative
- INNOVIVE Pharmaceuticals
- INO-4885
- INO-8875
- Inotek
- Inotek Pharmaceuticals
- Inovio
- InSite Vision
- Insmed
- insomnia
- Inspire Pharmaceuticals
- insulin
- insurance companies
- Intanza
- Intas
- Integral Molecular
- Integrated Biopharma
- Integrated Biotherapeutics
- Intelect Medical
- Intercell
- Intermune
- International Stem Cell Corp
- InterWest Partners
- Intradigm
- Introgen Therapeutics
- investigation
- investigators
- investment
- investments
- Investor
- Invitrogen
- Invus
- IoGen
- Iomai
- Iorcaserin
- IP
- IPI-493
- IPI-504
- IPI-926
- ipilimumab
- IPSC
- Ipsen
- Ipsogen
- Ireland
- Iressa
- Ironwood Pharmaceuticals
- Irritable Bowel Syndrome
- Isconova
- Isentress
- Isis
- ISIS 301012
- ISIS 388626
- Isis Pharmaceuticals
- Isolagen
- Isotechnika
- Israel
- ISTA Pharmaceuticls
- Itero
- Itero Biopharmaceuticals
- ITI Life Sciences
- IXEMPRA
- J. Craig Venter
- J. Michael Pearson
- Jack Lief
- JADO Technologies
- James Bianco
- James Cornelius
- James Mullen
- James S. Kuo
- James Shannon
- James White
- Janssen
- Januvia
- Japan
- Japan Tobacco
- jassen
- Jassen Galapagos
- Javelin Pharmaceuticals
- Javier San Martin
- Jazz Pharmaceuticals
- JDS Pharmaceuticals
- Jean Stéphenne
- Jean-Claude Leroy
- Jean-Luc Belingard
- Jean-Marc Huet
- Jean-Pierre Garnier
- Jeffrey H. Buchalter
- Jeffrey Kindler
- Jennerex
- Jeol Lexchin
- Jerini
- Jexys Pharmaceuticals
- JHP Pharmaceuticals
- Jim Kerstetter
- job cuts
- Joe Bolen
- John Babich
- John C. Martin
- John Dyer
- John Johnson
- John Knopf
- John LaForge
- John LaMattina
- John Lechleiter
- John Maraganore
- John McCain
- John Milligan
- John Oyler
- John P. Longenecker
- John P. Walker
- John Patterson
- Johns Hopkins
- Johnson & Johnson
- Jolee Mohr
- Jon P. Stonehouse
- Jon Symonds
- Joseph Yanchik
- Journal of the American Medical Association
- JTT-305
- Juergen Ernst
- JUPITER study
- Justiva
- Juvaris BioTherapeutics
- JZP-4
- JZP-7
- K-RAS gene
- KAI Pharmaceuticals
- KAI-9803
- KaloBios
- Kamada
- Kari Stefánsson
- Karl Ludwig Kley
- Karo Bio
- KB2115
- Keith Carter
- Keith Leonard
- Kelly Martin
- Keppra
- Keryx Biopharmaceuticals
- Ketek
- Kevin Sharer
- Kiadis Pharma
- kidney cancer
- kidney disease
- kinase
- King Pharmaceuticals
- Kingsbridge Capital
- Kirsten Drejer
- Kleanthis Xanthopoulos
- Kleiner Perkins Caufield & Byers
- Knome
- Knopp Neurosciences
- Kogenate
- Kohl
- Konrad Hochedlinger
- Kos Parmaceuticals
- Kowa
- KRX-0401
- Kuvan
- KV Pharmaceutical
- Kynapid
- Kyowa Hakko
- Kyphon
- Kythera Biopharmaceuticals
- L. Patrick Gage
- Labopharm
- Lacosamide
- Lance Ignon. James P. Panek
- Langdon Miller
- Lannett
- lansoprazole
- Larry Goldstein
- Latin America
- Latisse
- Laurie Halloran
- Lawrence Bloch
- Lawrence Tamarkin
- lawsuits
- layoff
- layoffs
- LEAD Therapeutics
- legislation
- Lehman Brothers
- Leo Pharma
- Leslie Browne
- Letairis
- leukemia
- Lev
- Lev Pharmaceuticals
- Levaquin
- Levemir
- Levitra
- Lexapro
- Lexicon
- Lexiscan
- LGD-4665
- Licensing deals
- Life Science Pharmaceuticals
- Ligand
- Ligand Pharmaceuticals
- Light Sciences Oncology
- LigoCyte
- LigoCyte Pharmaceuticals
- Linaclotide
- LineaGen
- Link Medicine
- Lipid Sciences
- Lipitor
- Liraglutide
- Lithium QD
- Liver
- Living Cell Technologies
- Lobbying
- Longevity
- lorcaserin
- Lovenox
- LSP
- Lu AA21004
- Lucentis
- Lumavita
- Lumigan
- Lundbeck
- lung cancer
- Lunivia
- lupus
- Lupus Nephritis
- Lusedra
- LX6171
- LXR-623
- LY156735
- LY2140023
- lymphoma
- MabCure
- MabThera
- MacroGenics
- MacroGenitcs
- Macugen
- macular degeneration
- major depressive disorder
- major market trends
- Malvinder Mohan Singh
- MammaPrint
- Mannkind
- manufacturing
- MAP Pharmaceuticals
- Marburg Fever
- Mario Capecchi
- Mark Heesen
- Mark J. Fitzpatrick
- Mark Levin
- Mark McDade
- market access strategies
- Martin Evans
- Martin Mackay
- Martin Madaus
- Martin Mattingly
- Martin O'Malley
- Martin Simonetti
- Maryland
- Massachusetts
- Massachusetts Biotechnology Council
- Matt Winkler
- Matthew Pfeffer
- Matuzumab
- maximize
- Maxy-4
- MAXY-alpha
- MAXY-G34
- Maxygen
- Mayne Pharma
- Mayo Clinic
- Mayo Clinical Trial Services
- MBP8298
- McGill University
- McNeil
- MDRNA
- MDS
- MDX-1106
- Meda
- Medarex
- Medgenics
- Medicago
- Medical device
- medical device news
- Medicare
- MediciNova
- Medicis
- Medigen
- MediGene
- MedImmune
- MediQuest Therapeutics
- Meditrina
- Medivation
- Medtronic
- Melanoma
- Melphalan
- MEM 3454
- Memory Pharmaceuticals
- meningitis
- Menopause
- Menvo
- Merck
- Merck BioVentures
- Merck KgAA
- Merck Serono
- Merger
- mergers and acquisitions
- Mergers and Acqusitions
- Mergers and Acqusitions
- Merial Animal Health
- Merlin Biosciences
- MET inhibition
- Metabasis Therapeutics
- Metabolic disorders
- Metabolon
- Metastasis
- Metastatix
- MethylGene
- Metozolv
- MF59
- MGCD0103
- MGI Pharma
- Michael Loberg
- Michelle Chang
- Michigan
- Microbia
- MicroIslet
- Micromet
- microplasmin
- microRNA
- MiddleBrook Pharmaceuticals
- mifamurtide
- Migenix
- migraine
- Mike Bonney
- Mike Leavitt
- Mike Varney
- Miles White
- milestones
- Millennium Pharmaceuticals
- Millipore
- Minnesota
- minorities
- mipomersen
- Miragen Therapeutics
- Mircera
- Mirina Corporation
- miRNA
- Mirus
- Mistral Pharma
- MIT
- Mitsubishi Tanabe Pharma
- MK-0524A
- MK-677
- Molecular Biometrics
- molecular diagnostics
- Molecular Insight Pharmaceuticals
- molecules
- Momenta Pharmaceuticals
- Moncef Slaoui
- monoclonal antibodies
- monoclonal antibody
- MonoGen
- Moraga
- MorphoSys
- Morphotek
- Morvus
- motavizumab
- motesanib
- Motivizumab
- Movetis
- Moxifloxacin
- Mozobil
- MPM Capital
- MRSA
- MSX-122
- Multaq
- multikine
- multiple myeloma
- multiple sclerosis
- Mundipharma
- Muscular Dystrophy
- Myasthenia Gravis
- Myelodysplastic Syndromes
- myeloma
- Mylan Laboratories
- Mylan Pharmaceuticals
- Myogen
- Myozyme
- Myriad Genetics
- Myriad Pharmaceuticals
- Nabi
- Nabi Piopharmaceuticals
- Nancy Wexler
- NanoBio Corp.
- Nanobodies
- Nanobody
- Nanogen
- Nanosphere
- nanotech
- nanotechnology
- naproxcinod
- naproxen
- nasal spray
- Nastech
- Nat Ricciardi
- National Institutes of Health
- natrecor
- Naturlose
- Navigenics
- NDA
- Nebido
- Needle Insertion
- Neil Gibson
- Nektar Therapeutics
- Neopharm
- Neratinib
- Nereus Pharmaceuticals
- Nerviano
- Neumune
- Neupro
- Neuralgia
- Neuralstem
- NeurAxon
- Neurimmune
- Neuro-Hitech
- Neurobiological Technologies
- Neurochem
- neurocrine biosciences
- Neurogen
- NeurogesX
- Neuromed
- neuropathic pain
- Neuroptix
- NeuroSearch
- NeuroVax
- Neuvenge
- new bird
- new blood
- New Drug Application
- New Drugs
- New England Journal of Medicine
- New Enterprise Associates
- New Jersey
- New Molecular Entity
- New York
- Newron
- newsday
- Nexavar
- Nexium
- NexMed
- nexterone
- NGX-4010
- NGX267
- NGX426
- Niacin
- NICE
- Nicholas Piramal
- Nicholas Stergis
- Nick Seay
- NiCox
- NicVAX
- nimotuzumab
- Nitec Pharma
- Nitromed
- NixOx
- NM100060
- NME
- NME approvals
- NMED-1077
- nNOS inhibitor
- Nobel Prize
- Noel Doheny
- Nomad Bioscience
- non-Hodgkin's lymphoma
- non-small cell lung cancer
- North Carolina
- North Shore Life Sciences Accelerator
- Northfield Laboratories
- Northstar Neuroscience
- Northwest Biotherapeutics
- Northwick Park
- NovaBay
- Novacea
- NovaDel
- Novagali
- Novalar Pharmaceuticals
- Novartis
- Novavax
- Noven
- Noven Pharmaceuticals
- Novexel
- Novo Nordisk
- Novocell
- Novogen
- NovoSeven
- Novosom
- Nplate
- NPS Pharmaceuticals
- Numerate
- Nuon Therapeutics
- Nuren Pharmaceuticals
- Nuvelo
- Nuvion
- NVA237
- NVCA
- Nventa
- NXN-188
- Nycomed
- Nymox
- Obama Administration
- obesity
- obsessive-compulsive disorder
- OccuLogix
- Oceana Therapeutics
- Ocera Therapeutics
- OctoPlus
- Odanacatib
- ofatumumab
- offshore outsourcing
- OGX-011
- Oliver Smithies
- Omigard
- Omni International
- OMP- 21M18
- Omrix
- Omrix Biopharmaceuticals
- Oncalis
- OncoGenex
- Oncology
- OncoMed Pharmaceuticals
- OncoMethylome
- Onconova Therapeutics
- Oncophage
- Oncoscience
- Oncothyreon
- Onexa
- Onglyza
- Ono Pharmaceutical
- Onyx
- Onyx Pharmaceuticals
- opbesity
- Opexa
- OpGen
- Opioid Analgestic
- Opko
- OPT-80
- Optherion
- optimal pricing
- Optimer Pharmaceuticals
- Oracea
- orBec
- Orchestra Therapeutics
- Orchid Cellmark
- Orchid Chemicals
- Orexigen Therapeutics
- Orexin
- Organogenesis
- Organon
- Origenis
- Oritavancin
- orlistat
- orphan drug status
- Orphan Europe
- Orphan Status
- Ortho Biotech
- Ortho-McNeil
- Orthos Europe
- Oscient Pharmaceuticals
- OSI Pharmaceuticals
- osiris therapeutics
- Osmotica
- Osprey Pharmaceuticals
- Ostarine
- osteoarthritis
- Osteologix
- osteoporosis
- osteoprorosis
- OTC drugs
- Otsuka
- Otsuka Pharmaceuticals
- outbreak
- outsourcing
- Outsourcing Deals
- ovarian cancer
- Ovation Pharmaceuticals
- Oxford BioMedica
- Oxford Bioscience Partners
- Oxford University
- OXiGENE
- Oxycontin
- Oxycyte
- Oxygen Biotherapeutics
- Oxytrol
- p53 biomarker
- Pacgen Biopharmaceuticals
- Pacific Biosciences
- Pacira Pharmaceuticals
- Paclitaxel
- pagoclone
- Pain Therapeutics
- Pain Therapies
- pain therapy
- painkiller
- Paion
- Paladin Labs
- Palatin Technologies
- Palo Alto
- Panacea Biotec
- Panacos
- pancreatic cancer
- pandemic
- pandemic flu
- Pandemic Influenza
- Panomics
- Paoin
- Paolo Paoletti
- Par Pharmaceutical
- Paratek Pharmaceuticals
- Parexel
- Parion Sciences
- Parkinson's
- PARP inhibitor
- partnership
- partnerships
- patent
- Patent infringement
- Patent news
- patent rules
- patents
- Pathway Therapeutics
- patient recruitment
- Patrick Vallance
- Patrik De Haes
- Paul Bisaro
- Paul Desjourdy
- Paul Herrling
- Paul Maeder
- Paul Rubin
- Paul Touhey
- pazopanib
- PBMs
- PDI
- PDL BioPharma
- PDL241
- PDUFA
- Pearl Therapeutics
- Pegasus Biologics
- Pegasys
- Pegintron
- Peking University
- Pennsylvania
- Peplin
- peptide
- Peramivir
- Perampanel
- Percivia
- Peregrine
- Perkinelmer
- Perlegen
- Perrigo
- personalized medicine
- Pervasis Therapeutics
- Peter Fellner
- Peter Kim
- Peter Meldrum
- Pevion Biotech
- PF-03187207
- Pfizer
- Pfizer Global Research
- Phamrion
- Pharma news
- Pharmacells
- pharmaceutical companies
- pharmaceutical company
- pharmaceutical industry
- pharmaceutical outsourcing
- pharmaceuticals
- Pharmacopeia
- pharmacovigilance
- PharmaNet
- Pharmatech
- Pharmatech Oncology
- Pharmathene
- Pharmaxis
- Pharmexa
- Pharming
- Pharmion
- Pharmos
- Pharsight
- Phase
- Phase 2 Discovery
- Phase I
- Phase II
- Phase III
- Phase IV
- Phenomix Corporation
- Philanthropy
- Phillip Archinard
- Phillipe Archinard
- Phoenix
- Phrma
- physicians
- Phytopharm
- PI-88
- PI3-K
- Picoplatin
- Piedmont Pharmaceuticals
- Pierre Fabre Medicament
- Pill-Plus
- pimavanserin
- Pioneer
- pipeline
- Pipex
- Piramed
- Pirbright
- Pittsburgh Center for Vaccine Research
- Pittsburgh Life Sciences Greenhouse
- Pivotal BioSciences
- PixelEXX Systems
- PL-100
- Plan B
- Plavix
- Plethora Solutions
- Pliva
- PMA
- PML
- PN 400
- PN400
- Point Biomedical
- Point Therapeutics
- polyheme
- Polymer Technology Group
- Polyphor
- Poniard
- Portola Pharmaceuticals
- Postherpetic Neuralgia
- Pozen
- PPD
- Pradaxa
- pralatrexate
- pramiconazole
- Prana
- prasugrel
- Precedex
- Precision Therapeutics
- preclinical
- Predictive Biosciences
- PregLem
- PreMD
- Presidio Pharmaceuticals
- Pressure BioSciences
- Prestwick Pharmaceuticals
- Prevacid
- Prevalere
- Prexige
- Prezista
- PricewaterhouseCoopers
- pricing
- Prim